Another BCMA-targeted agent has arrived for the treatment of multiple myeloma. | After a delay, Regeneron’s BCMA-directed ...

Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...

The amended dosing regimen was approved based on results from a post hoc analysis of the phase 2 MagnetisMM-3 trial.

How did we get here? Until now, vaccines for all children under age 12 had been available under emergency use authorization ...

The FDA approval comes less than a week after it was announced by U.S. officials that booster shots will be needed for those who took the two-dose Pfizer or Moderna vaccine.

FDA head Marty Makary said the agency may fast-track drugs from companies that “equalize” the cost of medicines between the U ...

Since 2020, investors have been rallying behind shares of Pfizer and Germany's BioNTech, two companies that were poised to play a crucial role in helping bring an end to a devastating pandemic.

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two COVID-19 vaccines ...

FDA approves Pfizer’s eczema treatment New York City-based Pfizer earned approval from the Food and Drug Administration for its topical drug Eucrisa, reports Reuters.

Arvinas and Pfizer have filed for U.S. Food and Drug Administration approval of their proposed breast-cancer drug vepdegestrant in certain patients with estrogen-receptor mutations. Arvinas on ...

The FDA will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to green-lighting shots that have been recommended broadly to the public.